Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
Q5 LONG ANSWER 10M ★ High-yield

Describe dry eye disease with its classification, investigation and management.

Ophthalmology · 3rd Professional

Nature and Classification

Dry eye disease is a multifactorial disease of the ocular surface characterised by loss of homeostasis of the tear film, with tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormality.

  • Two concepts IN that definition drive modern treatment: hyperosmolarity, which is the core mechanism damaging the epithelium and triggering inflammation; and inflammation, which is why anti-inflammatory treatment works and why lubricants alone often do not
  • The vicious circle — reduced or unstable tears raise osmolarity; hyperosmolarity damages epithelial and goblet cells and releases inflammatory mediators; inflammation further damages the glands and the goblet cells and damages the corneal nerves; and the resulting reduction in reflex secretion perpetuates the cycle. Breaking the circle, not merely wetting the eye, is the aim
CategoryCauses
Aqueous-deficient — sjogren
  • Primary Sjogren syndrome (dry eye, dry mouth and autoantibodies) and secondary Sjogren with rheumatoid arthritis, systemic lupus erythematosus or systemic sclerosis.
  • Anti-Ro (SS-A) and anti-La (SS-B) antibodies; lymphocytic infiltration of the lacrimal and salivary glands, with a raised lifetime risk of lymphoma
Aqueous-deficient — non-sjogrenAge-related lacrimal gland atrophy.
Evaporative — lid-relatedMeibomian gland dysfunction and blepharitis (the leading cause); lid aperture disorders — proptosis, lagophthalmos, ectropion; and a low blink rate with screen work, reading and in Parkinson disease
Evaporative — surface-relatedVitamin A deficiency, which causes mucin deficiency through goblet cell loss; topical drugs and preservatives; contact lens wear; and allergic eye disease
Iatrogenic and environmentalSystemic drugs — antihistamines, anticholinergics, beta-blockers, diuretics, isotretinoin, antidepressants and hormone therapy; refractive surgery.

Symptoms, Signs and Investigation

  • Symptoms — grittiness, burning, foreign-body sensation, itching, photophobia, fluctuating blurred vision that clears on blinking, contact lens intolerance, and — paradoxically — watering from reflex hypersecretion
  • A characteristic feature is that symptoms exceed signs, particularly early; and in severe long-standing disease with corneal nerve damage the reverse may be true, with marked signs and few symptoms
  • Symptoms are worse with reading, screen work, driving, air conditioning, wind and in the evening.
TestMethod and interpretation
Tear break-UP time (TBUT)
  • Fluorescein is instilled and the time to the first dry spot measured after a blink.
  • Less than 10 seconds is abnormal, and a short TBUT with a normal Schirmer indicates evaporative disease.
  • It is the simplest and most useful test
Schirmer I test
  • A 5 × 35 mm filter strip in the lower fornix for 5 minutes, without anaesthetic, measuring total (basal plus reflex) secretion.
  • Less than 10 mm is abnormal and less than 5 mm is severe.
  • Performed with anaesthetic it measures basal secretion.
  • It is poorly reproducible and normal in evaporative and mucin-deficient dry eye — which is its principal limitation
Fluorescein stainingStains areas of epithelial loss on the cornea; graded by the Oxford or NEI scheme
Lissamine green or rose bengalStain devitalised and unprotected cells, and are better for the conjunctiva. Rose bengal stings considerably; lissamine green is equally informative and comfortable, and has replaced it
Tear osmolarityRaised above 308 mOsm/L; a direct measure of the core mechanism and useful for monitoring
Meibography and interferometryImage gland dropout and the lipid layer thickness
Matrix metalloproteinase-9A point-of-care marker of ocular surface inflammation
Systemic testsAnti-Ro and anti-La, rheumatoid factor, ANA, ESR; salivary gland biopsy where Sjogren is suspected

Management

  • Treatment is a ladder, and severity determines the rung:
  • Step 1 — education and environment: explain that the condition is chronic and controllable rather than curable; take breaks from screen work and blink deliberately (the blink rate falls by more than half at a screen); lower the screen below eye level to reduce the exposed surface area; humidify; avoid direct air conditioning and fans; and review systemic drugs with the physician
  • Step 1 — lid hygiene with warm compresses and massage for meibomian dysfunction.
  • Step 1 — tear substitutes: drops by day, gels and ointment at night. Preservative-free preparations are essential above about four instillations daily.

All questions in The Eyelids and Lacrimal Apparatus

  1. Q1Describe the anatomy of the eyelid and the lid margin diseases. ★
  2. Q2Describe entropion, ectropion and trichiasis with their management. ★
  3. Q3Describe the benign and malignant tumours of the eyelid. ★
  4. Q4Describe the lacrimal drainage system and the assessment of a watering eye. ★
  5. Q5Describe dry eye disease with its classification, investigation and management. ★
  6. SN1Describe chalazion and hordeolum with their management. ★
  7. SN2Describe congenital nasolacrimal duct obstruction with its management. ★
  8. SN3Describe dacryocystitis and the operation of dacryocystorhinostomy. ★
  9. SN4Describe the disorders of the lacrimal gland. ★
  10. SN5Describe the ocular management of facial nerve palsy. ★
  11. SN6Describe blepharospasm and lid retraction. ★
  12. SN7Describe the assessment and repair of eyelid injuries.

Every Ophthalmology chapter →

Scroll to Top